Discuss Abbott Laboratories
Abbott Laboratories
WKN: 850103 / Symbol: ABT / Name: Abbott / Aktie / Pharmazeutika / Large Cap /
95,25 €
0,42 %
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $126.00 to $128.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Evercore ISI from $120.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Owens Corning diskutieren